Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK

R. Batool, M. Julve, M. Sadiq, S. Rahman, T. Mansy, N. Mathiyalagan, S. Khan, J. Evans, D. Saleh, E. Karapanagiotou, E. Josephides, R. Dunn, A. Hossam, P. Earwaker, M.I. Kashif, M. Sivaramalingam, H. Hassan, R. Shah, N.S. Osman, P. Wilson, S.A. Raza, L. Cambell, G. Clements, T. Aghadiuno, H. Talha, A. Iqbal, A. Zurgham, A. Datta, S. Mahar, O. Kennedy, V. Bacila, H. Robbins, S. Watkins, T. Newsom-Davis, Q. Ghafoor

Open source

DOI
10.1016/j.clon.2026.104323
Published
2026-11
Container
Clinical Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clon.2026.104323,
  title = {Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK},
  author = {R. Batool and M. Julve and M. Sadiq and S. Rahman and T. Mansy and N. Mathiyalagan and S. Khan and J. Evans and D. Saleh and E. Karapanagiotou and E. Josephides and R. Dunn and A. Hossam and P. Earwaker and M.I. Kashif and M. Sivaramalingam and H. Hassan and R. Shah and N.S. Osman and P. Wilson and S.A. Raza and L. Cambell and G. Clements and T. Aghadiuno and H. Talha and A. Iqbal and A. Zurgham and A. Datta and S. Mahar and O. Kennedy and V. Bacila and H. Robbins and S. Watkins and T. Newsom-Davis and Q. Ghafoor},
  year = {2026},
  journal = {Clinical Oncology},
  doi = {10.1016/j.clon.2026.104323},
  url = {https://doi.org/10.1016/j.clon.2026.104323}
}

RIS

TY  - JOUR
TI  - Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK
AU  - R. Batool
AU  - M. Julve
AU  - M. Sadiq
AU  - S. Rahman
AU  - T. Mansy
AU  - N. Mathiyalagan
AU  - S. Khan
AU  - J. Evans
AU  - D. Saleh
AU  - E. Karapanagiotou
AU  - E. Josephides
AU  - R. Dunn
AU  - A. Hossam
AU  - P. Earwaker
AU  - M.I. Kashif
AU  - M. Sivaramalingam
AU  - H. Hassan
AU  - R. Shah
AU  - N.S. Osman
AU  - P. Wilson
AU  - S.A. Raza
AU  - L. Cambell
AU  - G. Clements
AU  - T. Aghadiuno
AU  - H. Talha
AU  - A. Iqbal
AU  - A. Zurgham
AU  - A. Datta
AU  - S. Mahar
AU  - O. Kennedy
AU  - V. Bacila
AU  - H. Robbins
AU  - S. Watkins
AU  - T. Newsom-Davis
AU  - Q. Ghafoor
PY  - 2026
JO  - Clinical Oncology
DO  - 10.1016/j.clon.2026.104323
UR  - https://doi.org/10.1016/j.clon.2026.104323
ER  - 

APA

Batool, R., Julve, M., Sadiq, M., Rahman, S., Mansy, T., Mathiyalagan, N., Khan, S., Evans, J., Saleh, D., Karapanagiotou, E., Josephides, E., Dunn, R., Hossam, A., Earwaker, P., Kashif, M., Sivaramalingam, M., Hassan, H., Shah, R., Osman, N., Wilson, P., Raza, S., Cambell, L., Clements, G., Aghadiuno, T., Talha, H., Iqbal, A., Zurgham, A., Datta, A., Mahar, S., Kennedy, O., Bacila, V., Robbins, H., Watkins, S., Newsom-Davis, T., & Ghafoor, Q. (2026). Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK. Clinical Oncology. https://doi.org/10.1016/j.clon.2026.104323

Source records